PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportstrypanosomiasis
MeSH D014352 - trypanosomiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D056986:Euglenozoa infections
0 Companies
0 Drugs
Success rate
D014352: 
Trypanosomiasis
9 Companies
1 Drug
$
Success rate
D004313:Dourine
0 Companies
0 Drugs
Success rate
D014353:African trypanosomiasis
4 Companies
2 Drugs
$
Success rate
D014354:Bovine trypanosomiasis
0 Companies
0 Drugs
Success rate
D014355:Chagas disease
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
HospiraPentamidine isethionate Pentamidine Isethionate  1992-06-30   
Fresenius KabiPentamidine isethionate Nebupent  1989-06-15   
Pentamidine isethionate Pentam  1984-10-16   
BaxterPentamidine isethionate Pentamidine Isethionate  1995-12-18   
Seton PharmaceuticalsPentamidine isethionate Pentamidine Isethionate  2017-09-28   
XGen PharmaceuticalsPentamidine isethionate Pentamidine Isethionate  2022-03-17   
Armour PharmaceuticalPentamidine isethionate Pentacarinat  1994-04-28   
Avet LifesciencesPentamidine isethionate Pentamidine Isethionate  2021-01-07   
AllerganPentamidine isethionate Pentamidine Isethionate  1995-08-17   
X-GEN PHARMACEUTICALSPentamidine isethionate Pentamidine Isethionate  2023-01-20   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
0%
0/0
Phase 3
67%
2/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use